Baseline rCBF (mL/100 g/min) | Post-acetazolamide rCBF (mL/100 g/min) | VR | ||||
---|---|---|---|---|---|---|
r | P | r | P | r | P | |
PSV (cm/s) | 0.32 | .02 | 0.39 | .006 | NS | |
EDV (cm/s) | 0.38 | .006 | 0.42 | .003 | NS | |
TMV (cm/s) | 0.38 | .007 | 0.44 | .002 | NS | |
Diameter (mm) | NS | 0.33 | .02 | 0.40 | .005 | |
Blood flow volume (mL/s) | NS | 0.48 | .0006 | 0.39 | .006 |
Note:—rCBF indicates regional cerebral blood flow; VR, vasoreactivity to acetazolamide; PSV, peak systolic velocity; EDV, end diastolic velocity; TMV, time-averaged mean velocity; NS, not significant.